MedTrace Logo

Remicade® Crohn's Disease Registry Across Canada (Study P02793)

NCT00755937 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 556

Last updated 2015-06-22

Study results available
· View outcomes & findings →

Summary

This registry is a multi-center, prospective, observational program that will gather and analyze data on subjects with Crohn's disease being treated with Remicade® as per approved product monograph in Canada. In contrast to a controlled clinical trial, there is no imposed experimental intervention and treatment with Remicade® is determined solely by the subject's physicians. Thus, the data captured and reported in this registry will reflect a "real world" approach to the treatment of Crohn's disease with Remicade®.

Conditions

Interventions

OTHER

Data collection post infusion

Sponsors & Collaborators

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-02-28
Primary Completion
2007-09-30
Completion
2007-09-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00755937 on ClinicalTrials.gov